{"id":431859,"title":"Notice to stakeholders – Implementation of ICH M13A: Bioequivalence for immediate release solid oral dosage forms - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T06:48:51.901000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-ich-m13a-bioequivalence-immediate-release-solid-oral-dosage-forms.html","snippet":"Notice to stakeholders – Implementation of ICH M13A: Bioequivalence for immediate release solid oral dosage forms June 27, 2025 Our file number: 25-102237-854 Background The International Council for Harmonisation (ICH)'s guideline entitled, ICH M13A: Bioequivalence for Immediate…","rawSnapshotUrl":"/api/snapshots/raw/431859","browseUrl":"https://replay.healtharchive.ca/job-6/20260102064851/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-ich-m13a-bioequivalence-immediate-release-solid-oral-dosage-forms.html#ha_snapshot=431859","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}